“…Testing their acute behavioral and neurochemical effects, we have previously identified four interesting neuroactive compounds for further analyses (Figure ), including two compounds with pronounced beneficial (anxiolytic/antidepressant-like) acute behavioral effects with increased brain serotonin and dopamine turnover ( N -(2-trifluoromethoxybenzyl)-2-(2,4-dimethoxyphenyl)ethylamine, 24H-NBOMe(F)) and N -(2-trifluoromethoxybenzyl)-2-(3,4-dimethoxyphenyl)ethylamine, 34H-NBOMe(F)), one compound with anxiogenic-like profile but no overt neurochemical profiles ( N -(2-fluorobenzyl)-2-(3,4-dimethoxyphenyl)ethylamine, 34H-NBF) acutely, and a behaviorally inert compound with overt neurochemical activity similar to 24H-NBOMe(F) and 34H-NBOMe(F), N -(2-chlorobenzyl)-2-(3,4-dimethoxyphenyl)ethylamine (34H-NBCl). Their ability to cross the zebrafish blood-brain barrier and enter the brain as well as chemical synthesis, chemical structures, and analytical data have already been reported previously. − Typically, in the 25X-NBOMe conventional nomenclature, the X (i.e., H for hydrogen here) indicates the substitution at position 4 of the phenethylamine moiety. , However, as 24H- and 34H- isomers carry a methoxy group at this position, they can also be described as 24- and 34-NBOMes, respectively . Here, we will specifically use the latter nomenclature, aiming at a greater clarity in order to emphasize that no other substitutions (beyond the two methoxy groups) were introduced at the phenyl ring of the phenethylamine moiety (also see similar examples in refs , , and ).…”